{"id":"W2941023559","doi":"10.1097/01.ju.0000556224.50163.ad","title":"MP43-01 PHASE 2 KEYNOTE-057 STUDY: PEMBROLIZUMAB FOR PATIENTS WITH HIGH-RISK NON–MUSCLE INVASIVE BLADDER CANCER UNRESPONSIVE TO BACILLUS CALMETTE-GUERIN","year":2019,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Medicine; Pembrolizumab; Bladder cancer; Cancer; Psychoanalysis; Internal medicine; Psychology; Immunotherapy","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001420668,0.0005772575,0.0007109698,0.0002150125,0.0003995274,0.001189086,0.000485351,0.001502732,0.009287702],"category_scores_gemma":[0.0006764883,0.0003080942,0.001373254,0.0002126557,0.0002633166,0.0007022945,0.0002952145,0.002545382,0.001641727],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006120544,"about_ca_system_score_gemma":0.001120406,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006888201,"about_ca_topic_score_gemma":0.001873166,"domain_scores_codex":[0.999698,0.0001438437,0.0000144997,0.00003380211,0.00005209315,0.00005773918],"domain_scores_gemma":[0.9995421,0.00007143377,0.00008566307,0.00002881768,0.00006211768,0.0002099641],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.514742,0.04785143,0.01159042,0.003171014,0.002700679,0.0006087356,0.0003039418,0.001395926,0.05719538,0.001864129,0.1082994,0.2502769],"study_design_scores_gemma":[0.5552671,0.3426829,0.02977872,0.0005374983,0.001027877,0.0006965413,0.000170128,0.001484326,0.00810804,0.0006506942,0.05953948,0.00005670211],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9073563,0.02288317,0.00166523,0.009584277,0.001781609,0.01121128,0.009576113,0.0003032596,0.03563881],"genre_scores_gemma":[0.909708,0.01299647,0.003564501,0.01452491,0.001488104,0.006994496,0.01147146,0.0001139305,0.0391381],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.009287702,"threshold_uncertainty_score":0.03107053,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01198551721572523,"score_gpt":0.2898276754528961,"score_spread":0.2778421582371709,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}